XTL Biopharmaceuticals Ltd. (TLV:XTLB)
Israel · Delayed Price · Currency is ILS · Price in ILA 1.900
+0.100 (5.56%)
Oct 1, 2026, 2:24 PM IDT
XTL Biopharmaceuticals Market Cap
XTL Biopharmaceuticals has a market cap or net worth of 25.16 million as of October 2, 2026. Its market cap has decreased by -28.62% in one year.
Market Cap
25.16M
Enterprise Value
24.92M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
1.90
ChartMarket Cap Chart
Since August 30, 2005, XTL Biopharmaceuticals's market cap has decreased from 805.44M to 25.16M, a decrease of -96.88%. That is a compound annual growth rate of -15.15%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 1, 2026 | 25.16M | 10.81% |
| Dec 31, 2025 | 22.71M | -72.15% |
| Dec 31, 2024 | 81.53M | 327.50% |
| Dec 31, 2023 | 19.07M | -14.63% |
| Dec 29, 2022 | 22.34M | -52.02% |
| Dec 30, 2021 | 46.56M | -7.60% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Bonus BioGroup | 210.26M |
| Matricelf | 77.30M |
| BioLineRx | 38.83M |
| Clal Biotechnology Industries | 37.96M |
| Purple Biotech | 32.42M |
| BioLight Life Sciences | 26.34M |
| Can-Fite BioPharma | 20.06M |
| Evogene | 19.51M |